SavedAdd your journal

Journals / Kolon ve Rektum Hastalıkları Dergisi / 2010 / Cilt: 20 - Sayı: 1

Irritable bowel syndrome

İrritabl barsak sendromu

B. Bülent MENTEŞ
Sezai LEVENTOĞLU
Pages
1–6
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we aimed to discuss IBS, especially its clinical features.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Irritable bowel syndrome (IBS) is an increasing frequent disease entity in city life.
📊
Key Findings & Data:Although its treatment is not surgical, IBS needs to be well understood by surgeons and gastroenterologists for differential diagnosis.
💡
Conclusion & Impact:In this article, we aimed to discuss IBS, especially its clinical features.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Irritable bowel syndrome (IBS) is an increasing frequent disease entity in city life. Although its treatment is not surgical, IBS needs to be well understood by surgeons and gastroenterologists for differential diagnosis. In this article, we aimed to discuss IBS, especially its clinical features.

Özet

İrritabl barsak sendromu (iBS) özellikle şehir insanında giderek daha sık rastlanan bir entidedir. Tedavisinin cerrahi olmamasına karşın, geniş semptom spektrumu nedeniyle ayırıcı tanıda cerrahlar ve gastroenterologlar tarafından iyi bilinmesi gereklidir. Bu temel konu yazısı kapsamında, iBS'nin özellikle klinik açıdan irdelenmesi amaçlanmıştır.

🔖

Cite This Article

MENTEŞ, B. B., LEVENTOĞLU, S. (2022). Irritable bowel syndrome. Kolon ve Rektum Hastalıkları Dergisi, Cilt: 20 - Sayı: 1, 1–6. https://ajindex.com/articles/575377

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643
  2. American College of Gastroenterology Task Force of Irritable Bowel Syndrome. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104Suppl 1:S1
  3. Everhart JE, Renault PF. Irritable bowel syndrome in office based practice in the United States. Gastroenterology 1991;100:998
  4. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500
  5. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: Heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799
  6. Chun AB, Wald A. Pathophysiology of irritable bowel syndrome.
  7. Serra J, Azpiroz F, Malagelada JR. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001;48:14
  8. Camilleri M, Heading RC, Thompson WG. Aliment Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Pharmacol Ther. 2002;16:1407-30
  9. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480
  10. Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey. Can J Gastroenterol 2005;19:231
  11. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390
  12. Chun AB, Wald A. Clinical manifestations and diagnosis of irritable bowel syndrome.
  13. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:2812
  14. Atkinson, W, Sheldon, TA, Shaath, N, Whorwell, PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004; 53:1459
  15. Bohmer, CJ, Tuynman, HA. The effect of a lactoserestricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: A 5-year follow-up study. Eur J Gastroenterol Hepatol 2001;13:941
  16. Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Da